slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 38,161-38,190
Pages 3,950
Rows per page 30
Component
38,161-38,190 of 118,471
01
Comera | Investor Presentation Deck | 22 slidesComera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations 2 hits
22
Comera | Investor Presentation Deck | 22 slidesComera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations 2 hits
09
MTD = Maximum Tolerated Dose; PR = Partial Response; RECIST = Response Evaluation Criteria in Solid Tumors; ORR = Objective Response Rate.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
25
The slide uses a table for market sizing and a structured layout to contrast 1L and 2L treatment options.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction2 hits
32
Compass Therapeutics | Investor Presentation Deck | 40 slidesCompass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
34
The slide uses a process flow diagram to show the transition from testing bispecific formats to the identification of the lead candidate CTX-8371.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
16
The slide depicts a virtuous cycle or flywheel model.Coursera | Results Presentation Deck | 39 slides · Coursera
Conference presentation Investor relations Beat · Situation & Context2 hits
20
The slide uses a grid-based layout to display a catalog of products. ACE indicates American Council on Education credit recommendations.Coursera | Results Presentation Deck | 39 slides · Coursera
Conference presentation Investor relations Beat · NeedLoop · Golden Circle2 hits
26
Includes footnote references for definitions and data sources.Coursera | Results Presentation Deck | 39 slides · Coursera
Conference presentation Investor relations Beat · DesireLoop · Quick Win Big Bet2 hits
27
The slide uses a split-layout with key metrics on the left and trend charts on the right.Coursera | Results Presentation Deck | 39 slides · Coursera
Conference presentation Investor relations Beat · DesireLoop · Quick Win Big Bet2 hits
09
Includes specific financial terms of the collaboration and regulatory milestones.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
16
Slide 16 of a pitch deck.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 2 hits
19
The slide highlights a key partnership milestone and the associated financial structure (upfront payment and potential milestones).Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
26
The slide uses a comparison table structure to map desired product features to specific Ovaprene design attributes.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
27
Includes details on milestone payments, royalties, and strategic support from Bayer.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
30
The slide highlights the lack of existing FDA-approved therapies for FSAD.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
31
Uses a visual inequality symbol to emphasize the distinction between FSAD and HSDD.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
34
The slide outlines the methodology and goals of a clinical trial, specifically mentioning the RESPOND study.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
36
Includes a table of pharmacokinetic parameters and a line chart showing plasma concentration over time.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
38
Dare Bioscience | Investor Presentation Deck | 54 slidesDare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
39
The slide uses a side-by-side comparison layout to contrast the biological route with the technical solution.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
40
The slide frames the market opportunity and clinical need for a non-oral hormone therapy.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
42
The slide details the specific regulatory strategy for a pharmaceutical product, focusing on the 505(b)(2) pathway.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
47
Includes clinical trial data and comparative pharmacokinetic data against oral tamoxifen.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
48
Text-dense clinical study summary slide with a red banner headline and subtitle; reports specific quantitative outcomes (e.g. p=0.04, 36 days, 17 women, dose levels 1-20 mg).Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
51
The slide outlines development phases from 2021 through 2026, including specific grant amounts.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
52
The slide uses a callout box to highlight the mechanism and benefits of GML.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
53
The slide highlights the clinical need for vaginal health solutions and the specific technical challenge of maintaining microbe viability in low-resource settings.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
10
Disney | Results Presentation Deck | 30 slidesDisney | Results Presentation Deck | 30 slides · Disney
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits
11
Disney | Results Presentation Deck | 30 slidesDisney | Results Presentation Deck | 30 slides · Disney
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits